Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-06-12T12:54:34.822Z Has data issue: false hasContentIssue false
  • English
  • Français

An Evaluation of the Impact of a Single-Dose Intravenous Immunoglobulin Regimen in the Treatment of Clostridium difficile Infections

Published online by Cambridge University Press:  02 January 2015

Mamoon A. Aldeyab ,
James C. McElnay ,
Michael G. Scott ,
Elizabeth Davies ,
Collette Edwards ,
Feras W. Darwish Elhajji ,
Geraldine Conlon ,
Fidelma A. Magee ,
Paul J. Barr  and
Mary P. Kearney
Mamoon A. Aldeyab*
Affiliation:
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, BT9 7BL Belfast, Northern Ireland, United Kingdom
James C. McElnay
Affiliation:
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, BT9 7BL Belfast, Northern Ireland, United Kingdom
Michael G. Scott
Affiliation:
Northern Health and Social Care Trust, Ballymena BT43 6DA, Northern Ireland, United Kingdom
Elizabeth Davies
Affiliation:
Northern Health and Social Care Trust, Ballymena BT43 6DA, Northern Ireland, United Kingdom
Collette Edwards
Affiliation:
Northern Health and Social Care Trust, Ballymena BT43 6DA, Northern Ireland, United Kingdom
Feras W. Darwish Elhajji
Affiliation:
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, BT9 7BL Belfast, Northern Ireland, United Kingdom
Geraldine Conlon
Affiliation:
Northern Health and Social Care Trust, Ballymena BT43 6DA, Northern Ireland, United Kingdom
Fidelma A. Magee
Affiliation:
Northern Health and Social Care Trust, Ballymena BT43 6DA, Northern Ireland, United Kingdom
Paul J. Barr
Affiliation:
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, BT9 7BL Belfast, Northern Ireland, United Kingdom
Mary P. Kearney
Affiliation:
Northern Health and Social Care Trust, Ballymena BT43 6DA, Northern Ireland, United Kingdom
*
Clinical and Practice Research Group, School of Pharmacy, Queen's University Belfast, BT9 7BL Belfast, Northern Ireland, United Kingdom (m.aldeyab@qub.ac.uk)
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 6 , June 2011 , pp. 631 - 633
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

References

1.Thompson, I. Clostridium difficile-associated disease: update and focus on non-antibiotic strategies. Age Ageing 2008;37:14–18.Google Scholar
2.McFarland, LV. Update on the changing epidemiology of Clostridium difficile-associated disease. Nat Clin Pract Gastroenterol Hepatol 2008;5:40–48.Google Scholar
3.Kyne, L, Warny, M, Qamar, A, Kelly, CRAsymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000;342:390–397.Google Scholar
4.Leffler, DA, Lament, JT. Treatment of Clostridium difficile-associated disease. Gastroenterology 2009;136:1899–1912.Google Scholar
5.Gerding, DN, Muto, CA, Owens, RC Jr.Treatment of Clostridium difficile infection. Clin Infect Dis 2008;46(suppl 1):S32–S42.CrossRefGoogle ScholarPubMed
6.Halsey, J. Current and future treatment modalities for Clostridium difficile-associated disease. Am J Health Syst Pharm 2008;65:705–715.CrossRefGoogle ScholarPubMed
7.O'Horo, J, Safdar, N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int J Infect Dis 2009;13:663–667.CrossRefGoogle ScholarPubMed
8.Aldeyab, MA, Devine, MJ, Flanagan, P, et al.Multi-hospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measures. Infect Control Hosp Epidemiol 2011;32(3):210–219.Google Scholar
9.Tobacman, JK. Assessment of comorbidity: a review. Clin Perform Quoi Health Care 1994;2:23–32.Google ScholarPubMed